Tag Archives: Leerink Swann

Highlights from the Leerink Swann Healthcare Conference

Over a hundred public companies, dozens of clinicians, and several regulators participated in investment firm Leerink Swann’s 2012 Healthcare Conference in mid-February. Press was barred from the event, but John Sullivan, Leerink’s director of research, gives PharmExec a few of the take-aways.
Posted in Biotech, Events, FDA, Gene therapy, leadership, Strategy, Technology | Also tagged , , , , , , , | Leave a comment
  • Categories

  • Meta